Internal Medicine Alert – February 28, 2006
February 28, 2006
View Issues
-
Fitness Now Comes in a Pill!
Rosiglitazone improves exercise capacity in individuals with Type 2 Diabetes. -
Cardiovascular Risk Factors for Predicting a Long Life
Participants in the Framingham Heart Study who had low levels of cardiovascular risk factors in middle age had longer overall survival and less morbidity when followed to age 85. Control of risk factors may have a major influence on reaching older age in good health. -
Carbs are OK: Certainly for Women
In the largest randomized dietary intervention trial conducted to date, a low-fat predominately carbohydrate diet resulted weight maintenance over 7.5 years in postmenopausal women compared with a control diet higher in fat. -
An Oral Solution for Partial Small Bowel Obstruction
The use of a laxative, a digestive aid, and a surfactant leads to speedier recovery from partial small bowel obstruction with less need for surgery. -
Pharmacology Update: Sunitinib Maleate Capsules (Sutent®)
The FDA has approved a new drug for the treatment of gastrointestinal stromal tumor and metastatic renal cell cancer. Sunitinib is an orally active, highly selective, multi-targeted tyrosine kinase inhibitor. The drug was given a priority review and was approved in less than 6 months. Sunitinib is marketed by Pfizer as Sutent®. -
Clinical Briefs By Louis Kuritzky, MD
Erectile Dysfunction and Subsequent Cardiovascular Disease; Oseltamivir Resistance during Influenza A Infection; Dietary Intake of Antioxidants and AMD